Compared with the control group (APP/PS1 mice with co-expression in mice with intact leptin receptor signaling), the novel developed mouse model (APPswe/PS1dE9 × db/+) showed noneating hyperglycemia, hypercholesterolemia, and hyperinsulinemia, with no alterations in body weight. The gene discussed is APP; the disease is Hyperinsulinemia.